Jennifer Chao
Director/Board Member bij ENDO INTERNATIONAL PLC
Vermogen: 10 $ op 31-03-2024
Actieve functies van Jennifer Chao
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ENDO INTERNATIONAL PLC | Director/Board Member | 17-02-2021 | - |
Independent Dir/Board Member | 17-02-2021 | - | |
CARDIOL THERAPEUTICS INC. | Director/Board Member | 15-03-2022 | - |
Independent Dir/Board Member | 15-03-2022 | - | |
Corestrategies Management LLC | Founder | 01-01-2008 | - |
Corporate Officer/Principal | - | - | |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Director/Board Member | - | - |
Loopbaan van Jennifer Chao
Eerdere bekende functies van Jennifer Chao
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
EDESA BIOTECH, INC. | Director/Board Member | 28-03-2022 | 01-06-2023 |
Independent Dir/Board Member | 28-03-2022 | 01-06-2023 | |
BIOSPECIFICS TECHNOLOGIES CORP. | Director/Board Member | 22-04-2015 | 23-10-2019 |
Chairman | 23-10-2019 | 02-12-2020 | |
Independent Dir/Board Member | 22-04-2015 | 02-12-2020 | |
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Analyst-Equity | - | 29-02-2008 |
Leerink Swann & Co. | Corporate Officer/Principal | - | - |
RBC Capital Markets, Inc.
RBC Capital Markets, Inc. Investment ManagersFinance Part of Royal Bank of Canada, RBC Capital Markets, Inc. provides investment advice. The private company is based in Albany, NY. | Corporate Officer/Principal | - | - |
Opleiding van Jennifer Chao
New York University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Canada | 3 |
Ierland | 2 |
Operationeel
Director/Board Member | 5 |
Independent Dir/Board Member | 4 |
Corporate Officer/Principal | 3 |
Sectoraal
Health Technology | 6 |
Finance | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
CARDIOL THERAPEUTICS INC. | Health Technology |
EDESA BIOTECH, INC. | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
BioSpecifics Technologies Corp.
BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology BioSpecifics Technologies Corp. engages in the development of an injectable collagenase clostridium histolyticum for multiple indications. It sells its products under the brand XIAFLEX. The company was founded in 1990 and is headquartered in Lynbrook, NY. | Health Technology |
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Finance |
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
RBC Capital Markets, Inc.
RBC Capital Markets, Inc. Investment ManagersFinance Part of Royal Bank of Canada, RBC Capital Markets, Inc. provides investment advice. The private company is based in Albany, NY. | Finance |
Leerink Swann & Co. | Finance |
Corestrategies Management LLC |
- Beurs
- Insiders
- Jennifer Chao
- Ervaring